Cointime update: Eli Lilly has agreed to acquire Calytrix Bio for up to $1.5 billion in cash. The deal is structured as an all-cash transaction with a total value capped at that amount. No further terms of the agreement were disclosed.
Eli Lilly to Acquire Calytrix Bio for Up to $1.5B in Cash
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
30m ago
Nvidia beats estimates; analysts flag lingering uncertainty over outlook
56m ago
Binance to Launch USDT Perpetual Contracts for Six TradFi Assets
5h ago
Anthropic Expected to Price IPO Above Range at $80+ Per Share
5h ago
Ark Invest Buys $2.7M of Block Shares as Stock Falls 4.4%
6h ago
Nvidia beats estimates; NVDA perp on Hyperliquid rises 4% to $161.7
7h ago
Anthropic Existing Investors Plan Billions in IPO Share Purchase